Budesonide/formoterol maintenance reliever therapy versus fluticasone furoate /vilanterol fixed-dose treatment of asthma on airway inflammation with adult asthma in 4-week treatment;Open-label, randomized, parallel-group comparative study
- Conditions
- Bronchial asthma
- Registration Number
- JPRN-UMIN000017042
- Lead Sponsor
- Hiroshima Allergy and Respiratory Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Not provided
The patient with the following exclusion criteria is not enrolled 1)Patient with the drug allergy 2)Infection in the absence of effective antimicrobial agents, patients with deep mycosis 3)Patient with tuberculous disease, or respiratory infection 4)Patient with abnormal chest X-ray image 5)Patient with respiratory disease and other respiratory infections in 8 weeks before inclusion 6)Patient is using the beta-blockers, including eye drops or patients with systemic corticosteroids to less than 30 days 7)Patient with serious complications 8)Smoking history of 10 pack years or more and with less than 6 months or by non smoking 9)Patient with pregnancy, or who hope for a pregnancy 10)Patient was deemed inappropriate research attending physician is incorporated into this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The comparison of amount of change in FeNO with NIOXmino between baseline and after 4 weeks treatment
- Secondary Outcome Measures
Name Time Method The comparison of the effect in the following background factors after 4week treatment; ACQ score Airway resistance with IOS FEV1.0 Frequency of SABA use